Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies
Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs)
27-Jun-2022 -
Merck announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new €59 million, 70,000 square foot facility, officially opened, brings ...
active pharmaceutical ingredients
cancer
cancer therapy
+1